Therapeutic angiogenesis of mouse hind limb ischemia by novel peptide activating GRP78 receptor on endothelial cells

Biochemical Pharmacology

Volumn 75, Issue 4, 2008, Pages 891-899

  Hardy, Britta ^a   Battler, Alexander ^b   Weiss, Chana ^a   Kudasi, Orly ^a   Raiter, Annat ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

Angiogenesis; Endothelial cells; GRP78; Hypoxia; Ischemia; Peptides

Indexed keywords

GLUCOSE REGULATED PROTEIN 78; HEAT SHOCK PROTEIN; MEMBRANE RECEPTOR; PEPTIDE BINDING MEMBRANE RECEPTOR; PEPTIDE LIBRARY; ROY PEPTIDE; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; C57BL MOUSE; CAPILLARY DENSITY; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; DRUG MECHANISM; DRUG SYNTHESIS; ENDOTHELIUM CELL; FEMALE; FEMORAL ARTERY; HINDLIMB; HISTOLOGY; HUMAN; HUMAN CELL; HYPOXIC CELL; IN VITRO STUDY; LASER DOPPLER FLOWMETRY; LIMB ISCHEMIA; MASS SPECTROMETRY; MOUSE; NONHUMAN; PERFUSION; PRECIPITATION; PRIORITY JOURNAL;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; FEMALE; HEAT-SHOCK PROTEINS; HINDLIMB; HUMANS; ISCHEMIA; MICE; MICE, INBRED C57BL; MOLECULAR CHAPERONES; NEOVASCULARIZATION, PHYSIOLOGIC; OLIGOPEPTIDES;

EID: 38649085349     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2007.10.008     Document Type: Article

References (26)

1. Conway M.E., Collen D., and Carmeliet P. Molecular mechanisms of blood vessel growth. Cardiovasc Res 49 (2001) 507-521
2. Ziche M., Donnini S., and Morbidelle L. Development of new drugs in angiogenesis. Curr Drug Targets 5 (2004) 485-493
3. Losordo D.W., and Dimmeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Circulation 109 (2004) 2487-2491
4. Jones W.S., and Annex B.H. Growth factors for therapeutic angiogenesis in peripheral arterial disease. Curr Opin Cardiol 5 (2007) 458-463
5. Bouis D., Kusumanto Y., Meijer C., Mulder N.H., and Hospers G.A. A review on pro and anti-angiogenic factors as targets of clinical intervention. Pharmacol Res 53 (2006) 89-103
6. Walsh D.A. Pathophysiological mechanisms of angiogenesis. Adv Clin Chem 44 (2007) 187-221
7. Willam C., Koehne P., Jurgensen J.S., Grafe M., Wagner K.D., Bachman S., et al. Tie2 receptor expression is stimulated by hypoxia and proinflammatory cytokines in human endothelial cells. Circ Res 87 (2000) 370-377
8. Idris N.M., Haider H.K.H., Goh M.W.K., and Sim E.K.W. Therapeutic angiogenesis for treatment of peripheral vascular disease. Growth Factors 22 (2004) 269-279
9. Lee R.J., Springer M.L., Blanco-Bose W.E., Shaw R., Ursell P.C., and Blau H.M. VEGF gene delivery to myocardium: deleterious effect of unregulated expression. Circulation 102 (2000) 898-901
10. Hardy B., Raiter A., Weiss C., Kaplan B., Tenenbaum A., and Battler A. Angiogenesis induced by novel peptides selected from a phage display library by screening human vascular endothelial cells under different physiological conditions. Peptides 3 (2007) 691-701
11. Jaffe E.A., Hoyer L.W., and Nachman R.L. Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clinic Invest 52 (1973) 2757-2764
12. Sun Q., Chen R.R., Shen Y., Mooney D.J., Rajagopalan S., and Grossman P.M. Sustained vascular endothelial growth factor delivery enhances angiogenesis and perfusion in ischemic hind limb. Pharm Res 22 (2005) 1110-1116
13. Cao R., Brakenhielm E., Pawliuk R., Wrarjaro D., Post M.J., Wahlberg E., et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9 (2003) 604-613
14. Schratzberger P., Kirchmair R., Vale P.R., and Losordo D.W. Therapeutic angiogenesis by gene transfer in critical limb and myocardial ischemia. Curr Pharm Des 9 (2003) 1041-1047
15. Couffinhal T., Silver M., Zheng L.P., Kearney M., Witzenbichler B., and Isner J.M. Mouse model of angiogenesis. Am J Pathol 152 (1998) 1667-1679
16. Li W., Shen W., Gill R., Corbly A., Jones B., Belagaje R., et al. High resolution quantitative computed tomography demonstrating selective enhancement of medium-size collaterals by placental growth factor-1 in the mouse hind limb. Circulation 113 (2006) 2445-2453
17. Li J., and Lee A.S. Stress induction of GRP/BIP and its role in cancer. Curr Mol Med 6 (2006) 45-54
18. Rao R.V., Peel A., Logvinova A., del Rio G., Hermel E., Yokota T., et al. Coupling endoplasmatic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett 514 (2002) 122-128
19. Mintz P.J., Kim J., Do K.A., Wang X., Zinner R.G., Cristofanilli M., et al. Fingerprinting the circulation repertoire of antibodies from cancer patients. Nat Biotechnol 21 (2003) 57-63
20. Arap M.A., Lahdenranta J., Mintz P.J., Hajitou A., Sarkis A.S., Arap W., et al. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. Cancer Cell 6 (2004) 275-284
21. Liu C., Bhattacharjee G., Boisvert W., Dilley R., and Edgington T. In vivo interrogation of the molecular display of atherosclerotic lesion surfaces. Am J Pathol 163 (2003) 1859-1871
22. Gonzalez-Gronow M., Cuchacovich M., Llanos C., Urzua C., Gawdi G., and Pizzo S.V. Postate cancer cell proliferation in vitro is modulated by antibodies agains glucose regulated protein 78 isolated from patients serum. Cancer Res 66 (2006) 11424-11431
23. Davidson D.J., Haskell C., Majest S., Kherzai A., Egan D.A., Walter A.K., et al. Kringle 5 of human plasminogen induces apoptosis of endothelial and tumor cells through surface-expressed glucose-regulated protein 78. Cancer Res 65 (2005) 4663-4672
24. Brunelle J.K., and Chandel N.S. Oxygen deprivation induced cell death: an update. Apoptosis 7 (2002) 475-482
25. Song M.S., Park Y.K., Lee J.H., and Park K. Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-e/ERK/AP1 signaling cascade. Cancer Res 61 (2001) 8322-8330
26. Jamora C., Dennert G., and Lee A.S. Inhibition of tumor progression by suppression of stress protein GRP78/BIP induction in fibrosarcoma B/C10ME. Proc Natl Acad Sci USA 93 (1996) 7690-7694